Patton Albertson Miller Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.13M | Buy |
39,923
+639
| +2% | +$74.8K | 0.51% | 60 |
|
|
2026
Q1 | $4.73M | Sell |
39,284
-475
| -1% | -$54.8K | 0.56% | 58 |
|
|
2025
Q4 | $4.19M | Sell |
39,759
-5,744
| -13% | -$539K | 0.49% | 65 |
|
|
2025
Q3 | $3.82M | Buy |
45,503
+3,953
| +10% | +$326K | 0.46% | 70 |
|
|
2025
Q2 | $3.29M | Sell |
41,550
-762
| -2% | -$60.6K | 0.43% | 75 |
|
|
2025
Q1 | $3.8M | Sell |
42,312
-23,005
| -35% | -$2.15M | 0.56% | 62 |
|
|
2024
Q4 | $6.5M | Buy |
65,317
+3,751
| +6% | +$387K | 0.87% | 45 |
|
|
2024
Q3 | $6.99M | Buy |
61,566
+372
| +0.6% | +$44.2K | 0.95% | 42 |
|
|
2024
Q2 | $7.58M | Buy |
61,194
+4,343
| +8% | +$559K | 1.08% | 32 |
|
|
2024
Q1 | $7.5M | Buy |
56,851
+3,819
| +7% | +$471K | 1.12% | 27 |
|
|
2023
Q4 | $5.78M | Buy |
53,032
+7,758
| +17% | +$805K | 0.96% | 38 |
|
|
2023
Q3 | $4.66M | Buy |
45,274
+808
| +2% | +$87.1K | 0.91% | 32 |
|
|
2023
Q2 | $5.13M | Sell |
44,466
-395
| -0.9% | -$44.8K | 0.99% | 27 |
|
|
2023
Q1 | $4.77M | Buy |
44,861
+2,874
| +7% | +$310K | 0.87% | 36 |
|
|
2022
Q4 | $4.66M | Buy |
41,987
+1,155
| +3% | +$118K | 0.86% | 34 |
|
|
2022
Q3 | $3.52M | Buy |
40,832
+1,888
| +5% | +$169K | 0.76% | 43 |
|
|
2022
Q2 | $3.55M | Buy |
38,944
+4,170
| +12% | +$370K | 0.73% | 43 |
|
|
2022
Q1 | $2.85M | Buy |
34,774
+3,061
| +10% | +$241K | 0.49% | 74 |
|
|
2021
Q4 | $2.43M | Sell |
31,713
-4,423
| -12% | -$352K | 0.39% | 84 |
|
|
2021
Q3 | $2.71M | Buy |
36,136
+1,273
| +4% | +$96.8K | 0.52% | 69 |
|
|
2021
Q2 | $2.71M | Sell |
34,863
-4,248
| -11% | -$316K | 0.62% | 61 |
|
|
2021
Q1 | $2.88M | Sell |
39,111
-27,539
| -41% | -$2.03M | 0.7% | 54 |
|
|
2020
Q4 | $4.72M | Sell |
66,650
-2,547
| -4% | -$195K | 1.12% | 17 |
|
|
2020
Q3 | $5.48M | Sell |
69,197
-1,274
| -2% | -$99.8K | 1.55% | 10 |
|
|
2020
Q2 | $5.2M | Buy |
70,471
+3,326
| +5% | +$250K | 1.51% | 10 |
|
|
2020
Q1 | $4.93M | Buy |
67,145
+19,485
| +41% | +$1.53M | 1.67% | 7 |
|
|
2019
Q4 | $4.14M | Sell |
47,660
-844
| -2% | -$69.3K | 1.08% | 15 |
|
|
2019
Q3 | $3.9M | Buy |
48,504
+25,868
| +114% | +$2.07M | 1.1% | 14 |
|
|
2019
Q2 | $1.85M | Buy |
22,636
+19,783
| +693% | +$1.51M | 0.53% | 61 |
|
|
2019
Q1 | $226K | Sell |
2,853
-52
| -2% | -$3.89K | 0.11% | 112 |
|
|
2018
Q4 | $213K | Sell |
2,905
-28,959
| -91% | -$2.04M | 0.11% | 116 |
|
|
2018
Q3 | $2.15M | Sell |
31,864
-37
| -0.1% | -$2.36K | 1.09% | 15 |
|
|
2018
Q2 | $1.85M | Buy |
+31,901
| New | +$1.8M | 0.93% | 30 |
|
|
2017
Q4 | – | Sell |
-3,273
| Closed | -$202K | – | 128 |
|
|
2017
Q3 | $202K | Sell |
3,273
-37
| -1% | -$2.24K | 0.09% | 127 |
|
|
2017
Q2 | $202K | Sell |
3,310
-296
| -8% | -$18K | 0.09% | 126 |
|
|
2017
Q1 | $218K | Sell |
3,606
-209
| -5% | -$12.7K | 0.09% | 129 |
|
|
2016
Q4 | $214K | Buy |
3,815
+456
| +14% | +$26.7K | 0.09% | 128 |
|
|
2016
Q3 | $200K | Buy |
+3,359
| New | +$196K | 0.09% | 130 |
|
|
2015
Q2 | – | Sell |
-4,954
| Closed | -$272K | – | 137 |
|
|
2015
Q1 | $272K | Buy |
4,954
+343
| +7% | +$19.4K | 0.11% | 128 |
|
|
2014
Q4 | $250K | Buy |
4,611
+390
| +9% | +$21.7K | 0.12% | 141 |
|
|
2014
Q3 | $239K | Sell |
4,221
-415
| -9% | -$23.3K | 0.12% | 142 |
|
|
2014
Q2 | $255K | Buy |
4,636
+70
| +2% | +$3.82K | 0.13% | 146 |
|
|
2014
Q1 | $247K | Sell |
4,566
-14
| -0.3% | -$725 | 0.13% | 150 |
|
|
2013
Q4 | $219K | Buy |
4,580
+75
| +2% | +$3.43K | 0.13% | 127 |
|
|
2013
Q3 | $205K | Buy |
+4,505
| New | +$206K | 0.12% | 117 |
|
Other funds holding MRK
ATO
QP
AAMU
Patton Albertson Miller Group's MRK Position: Q2 2026 in Review
Patton Albertson Miller Group increased its Merck (MRK) stake by 1.6% in Q2 2026, buying an estimated $74.8K and bringing the position to 39,923 shares worth $5.13M. The position accounts for 0.51% of the portfolio, ranked #60.
Patton Albertson Miller Group first reported a position in MRK in Q3 2013 and has held it in 45 quarters since. The position peaked at $7.58M in Q2 2024. 1,341 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Patton Albertson Miller Group held 39,923 shares of Merck worth $5.13M as of Q2 2026.
- Patton Albertson Miller Group bought 639 Merck shares in Q2 2026, an estimated $74.8K.
- Merck made up 0.51% of Patton Albertson Miller Group's portfolio in Q2 2026, its #60 holding.
- Patton Albertson Miller Group first reported a position in Merck in Q3 2013 and has held it in 45 quarters since.
- Patton Albertson Miller Group's Merck position peaked at $7.58M in Q2 2024.
- 1,341 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Patton Albertson Miller Group's 13F filing for Q2 2026, filed 22 Jul 2026.